Even in AAV patients without CDI, MPO-ANCA is more common in southern regions of Europe and Asia, whereas PR3-ANCA is more common in northern parts of the world (41). The gene discussed is PRTN3; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.